• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚私人中心寻求 COVID-19 检测患者的临床和流行病学特征:私营医疗保健在抗击疫情方面是否发挥作用?

Clinical and epidemiological characteristics of patients seeking COVID-19 testing in a private centre in Malaysia: Is there a role for private healthcare in battling the outbreak?

机构信息

Clinical Research Centre, Sunway Medical Centre, Selangor Darul Ehsan, Malaysia.

Department of Information & Communication Technologies, Sunway Medical Centre, Selangor Darul Ehsan, Malaysia.

出版信息

PLoS One. 2021 Oct 14;16(10):e0258671. doi: 10.1371/journal.pone.0258671. eCollection 2021.

DOI:10.1371/journal.pone.0258671
PMID:34648575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8516249/
Abstract

OBJECTIVE

This cross-sectional observational study summarized the baseline characteristics of subjects who underwent COVID-19 molecular testing in a private medical centre located in the state of Selangor in Malaysia between 1 Oct 2020 and 31 Jan 2021. We compared the baseline characteristics between subjects who were tested positive and negative of SARS-CoV-2 infection, and identified risk factors which may be predictive of SARS-CoV-2 positivity.

METHODS AND FINDINGS

A total of 36603 subjects who were tested for COVID-19 infection via molecular assays at Sunway Medical Centre between Oct 1, 2020 and Jan 31, 2021, and consented to participate in this observation study were included for analysis. Descriptive statistics was used to summarize the study cohort, whereas logistic regression analysis was used to identify risk factors associated with SARS-CoV-2 positivity. Among the reasons listed for COVID-19 screening were those who needed clearance for travelling, clearance to return to work, or clearance prior to hospital admission. They accounted for 67.7% of tested subjects, followed by the self-referred group (27.3%). Most of the confirmed cases were asymptomatic (62.6%), had no travel history (99.6%), and had neither exposure to SARS-CoV-2 confirmed cases (61.9%) nor exposure to patients under investigation (82.7%) and disease clusters (89.2%). Those who presented with loss of smell or taste (OR: 26.91; 95% CI: 14.81-48.92, p<0.001), fever (OR:3.97; 95% CI: 2.54-6.20, p<0.001), running nose (OR: 1.75; 95% CI:1.10-2.79, p = 0.019) or other symptoms (OR: 5.63; 95% CI:1.68-18.91, p = 0.005) were significantly associated with SARS-CoV-2 positivity in the multivariate logistic regression analysis.

CONCLUSION

Our study showed that majority of patients seeking COVID-19 testing in a private healthcare setting were mainly asymptomatic with low epidemiological risk. Consequently, the average positivity rate was 1.2% compared to the national cumulative positivity rate of 4.65%. Consistent with other studies, we found that loss of smell or taste, fever and running nose were associated with SARS-CoV-2 positivity. We believe that strengthening the capacity of private health institutions is important in the national battle against the COVID-19 pandemic, emphasizing the importance of public-private partnership to improve the quality of clinical care.

摘要

目的

本横断面观察性研究总结了 2020 年 10 月 1 日至 2021 年 1 月 31 日期间在马来西亚雪兰莪州的一家私人医疗中心进行 COVID-19 分子检测的受试者的基线特征。我们比较了 SARS-CoV-2 感染检测阳性和阴性受试者的基线特征,并确定了可能预测 SARS-CoV-2 阳性的危险因素。

方法和发现

共有 36603 名受试者在 2020 年 10 月 1 日至 2021 年 1 月 31 日期间在双威医疗中心接受 COVID-19 感染的分子检测,并同意参与这项观察性研究。描述性统计用于总结研究队列,而逻辑回归分析用于确定与 SARS-CoV-2 阳性相关的危险因素。列出的 COVID-19 筛查原因包括需要旅行、工作或住院前的清除。他们占检测受试者的 67.7%,其次是自我推荐组(27.3%)。大多数确诊病例为无症状(62.6%),无旅行史(99.6%),既无 SARS-CoV-2 确诊病例接触史(61.9%),也无接触调查病例(82.7%)和疾病集群(89.2%)。出现嗅觉或味觉丧失(OR:26.91;95%CI:14.81-48.92,p<0.001)、发热(OR:3.97;95%CI:2.54-6.20,p<0.001)、流鼻涕(OR:1.75;95%CI:1.10-2.79,p=0.019)或其他症状(OR:5.63;95%CI:1.68-18.91,p=0.005)的患者在多变量逻辑回归分析中与 SARS-CoV-2 阳性显著相关。

结论

我们的研究表明,在私人医疗保健机构寻求 COVID-19 检测的大多数患者主要为无症状且具有低流行病学风险。因此,平均阳性率为 1.2%,而全国累计阳性率为 4.65%。与其他研究一致,我们发现嗅觉或味觉丧失、发热和流鼻涕与 SARS-CoV-2 阳性有关。我们认为,加强私立医疗机构的能力对于国家抗击 COVID-19 大流行非常重要,强调公私合作伙伴关系对于提高临床护理质量的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8e/8516249/85c3d97f8b95/pone.0258671.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8e/8516249/85c3d97f8b95/pone.0258671.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8e/8516249/85c3d97f8b95/pone.0258671.g001.jpg

相似文献

1
Clinical and epidemiological characteristics of patients seeking COVID-19 testing in a private centre in Malaysia: Is there a role for private healthcare in battling the outbreak?马来西亚私人中心寻求 COVID-19 检测患者的临床和流行病学特征:私营医疗保健在抗击疫情方面是否发挥作用?
PLoS One. 2021 Oct 14;16(10):e0258671. doi: 10.1371/journal.pone.0258671. eCollection 2021.
2
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020-a cross-sectional study.2020 年 3 月至 4 月德国柏林一个检测点的 SARS-CoV-2 感染的流行病学和临床特征:一项横断面研究。
Clin Microbiol Infect. 2020 Dec;26(12):1685.e7-1685.e12. doi: 10.1016/j.cmi.2020.08.017. Epub 2020 Aug 20.
3
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
4
Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.我们应该对哪些人进行 COVID-19 检测?在即时护理环境中,COVID-19 检测结果和患者结局的症状和风险因素问卷的表现。
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720981297. doi: 10.1177/2150132720981297.
5
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.加拿大艾伯塔省 COVID-19 大流行前两波期间 SARS-CoV-2 抗体的预疫苗阳性率。
Microbiol Spectr. 2021 Sep 3;9(1):e0029121. doi: 10.1128/Spectrum.00291-21. Epub 2021 Aug 18.
6
Performance of COVID-19 associated symptoms and temperature checking as a screening tool for SARS-CoV-2 infection.COVID-19 相关症状和体温检测作为 SARS-CoV-2 感染筛查工具的性能。
PLoS One. 2021 Sep 17;16(9):e0257450. doi: 10.1371/journal.pone.0257450. eCollection 2021.
7
Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020.2020 年 2 月 23 日至 5 月 24 日意大利大流行早期阶段对儿童进行的 SARS-CoV-2 检测的特征和危险因素:横断面研究。
Euro Surveill. 2021 Apr;26(14). doi: 10.2807/1560-7917.ES.2021.26.14.2001248.
8
COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.检测时的 COVID-19 症状与 SARS-CoV-2 检测门诊患者的阳性率之间的关系。
PLoS One. 2021 Dec 10;16(12):e0260879. doi: 10.1371/journal.pone.0260879. eCollection 2021.
9
Factors associated with SARS-CoV-2 positivity in 20 homeless shelters in Toronto, Canada, from April to July 2020: a repeated cross-sectional study.2020 年 4 月至 7 月期间加拿大多伦多 20 家无家可归者收容所中与 SARS-CoV-2 阳性相关的因素:一项重复横断面研究。
CMAJ Open. 2021 Mar 30;9(1):E302-E308. doi: 10.9778/cmajo.20200253. Print 2021 Jan-Mar.
10
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.基于社区人群的 SARS-CoV-2 感染相关症状和症状群:全州范围的流行病学研究结果。
PLoS One. 2021 Mar 24;16(3):e0241875. doi: 10.1371/journal.pone.0241875. eCollection 2021.

引用本文的文献

1
More than a Tripledemic: Influenza A Virus, Respiratory Syncytial Virus, SARS-CoV-2, and Human Metapneumovirus in Wastewater during Winter 2022-2023.不止三重疫情:2022 - 2023年冬季废水中的甲型流感病毒、呼吸道合胞病毒、新冠病毒和人偏肺病毒
Environ Sci Technol Lett. 2023 Jul 20;10(8):622-627. doi: 10.1021/acs.estlett.3c00385. eCollection 2023 Aug 8.

本文引用的文献

1
COVID-19 Epidemic in Malaysia: Epidemic Progression, Challenges, and Response.马来西亚的 COVID-19 疫情:疫情进展、挑战和应对。
Front Public Health. 2021 May 7;9:560592. doi: 10.3389/fpubh.2021.560592. eCollection 2021.
2
The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.无症状SARS-CoV-2感染的高流行率揭示了COVID-19的隐性传播。
Int J Infect Dis. 2021 Apr;105:656-661. doi: 10.1016/j.ijid.2021.02.100. Epub 2021 Feb 26.
3
Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study.
马来西亚重症 COVID-19 感染的临床特征和风险因素:一项全国性观察研究。
Lancet Reg Health West Pac. 2020 Nov;4:100055. doi: 10.1016/j.lanwpc.2020.100055. Epub 2020 Nov 17.
4
Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections.印度南部卡纳塔克邦新型冠状病毒感染的描述性流行病学:有症状与无症状感染的传播动态
EClinicalMedicine. 2021 Feb;32:100717. doi: 10.1016/j.eclinm.2020.100717. Epub 2021 Jan 6.
5
COVID's toll on smell and taste: what scientists do and don't know.新冠疫情对嗅觉和味觉的影响:科学家所了解和未知的情况。
Nature. 2021 Jan;589(7842):342-343. doi: 10.1038/d41586-021-00055-6.
6
Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system.新型双重多重实时 RT-PCR 检测方法可快速检测 SARS-CoV-2、流感 A/B 和呼吸道合胞病毒,使用的是 BD MAX 开放式系统。
Emerg Microbes Infect. 2021 Dec;10(1):161-166. doi: 10.1080/22221751.2021.1873073.
7
Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform.一种全自动、实验室开发的多重 RT-PCR 检测方法的临床评估,该方法在高通量平台上整合了双靶标 SARS-CoV-2 和流感 A/B 的检测。
J Med Microbiol. 2021 Feb;70(2). doi: 10.1099/jmm.0.001295.
8
Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study.在新冠疫情及应对措施不断发展的过程中,通过三个国家级数字监测平台对嗅觉丧失及其他与新冠病毒检测呈阳性相关的症状进行的一项观察性研究。
medRxiv. 2020 Dec 16:2020.12.15.20248096. doi: 10.1101/2020.12.15.20248096.
9
Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.在 hologic panther fusion 系统上全自动检测和区分大流行冠状病毒和地方性冠状病毒(NL63、229E、HKU1、OC43 和 SARS-CoV-2)。
J Med Virol. 2021 Jul;93(7):4438-4445. doi: 10.1002/jmv.26749.
10
The Association of "Loss of Smell" to COVID-19: A Systematic Review and Meta-Analysis.嗅觉丧失与 COVID-19 的相关性:系统评价和荟萃分析。
Am J Med Sci. 2021 Feb;361(2):216-225. doi: 10.1016/j.amjms.2020.09.017. Epub 2020 Nov 1.